Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade D 16.23 -2.46% -0.41
MGNX closed down 2.46 percent on Monday, June 24, 2019, on 60 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MGNX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Resistance Bearish -2.46%
Crossed Above 20 DMA Bullish -2.46%
Pocket Pivot Bullish Swing Setup -2.46%
Outside Day Range Expansion -2.46%
Wide Bands Range Expansion -2.46%
Fell Below 20 DMA Bearish -0.92%
Wide Bands Range Expansion -0.92%

Older signals for MGNX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Treatment Of Cancer Antibodies Immune System Autoimmune Diseases Monoclonal Antibodies Antibody Technology Platforms Novel Cancer
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.32
52 Week Low 9.87
Average Volume 860,153
200-Day Moving Average 17.5135
50-Day Moving Average 16.9292
20-Day Moving Average 16.2825
10-Day Moving Average 15.921
Average True Range 0.9378
ADX 18.63
+DI 20.2311
-DI 24.627
Chandelier Exit (Long, 3 ATRs ) 16.2766
Chandelier Exit (Short, 3 ATRs ) 16.7534
Upper Bollinger Band 18.9778
Lower Bollinger Band 13.5872
Percent B (%b) 0.49
BandWidth 33.10671
MACD Line -0.2933
MACD Signal Line -0.4363
MACD Histogram 0.1431
Fundamentals Value
Market Cap 597.23 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -3.87
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.06
Resistance 3 (R3) 17.12 16.90 16.92
Resistance 2 (R2) 16.90 16.69 16.87 16.88
Resistance 1 (R1) 16.57 16.56 16.46 16.51 16.83
Pivot Point 16.35 16.35 16.29 16.32 16.35
Support 1 (S1) 16.01 16.14 15.90 15.95 15.63
Support 2 (S2) 15.79 16.01 15.76 15.58
Support 3 (S3) 15.46 15.79 15.54
Support 4 (S4) 15.40